Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study of glepaglutide compared to placebo for patients with short bowel syndrome with intestinal failure

    Recruiting

    3 1
    Investigated Drugs:
    Austria Belgium Czechia Denmark Finland France +8
  • Study on How Apixaban and Teduglutide Affect Patients with Short Bowel Syndrome on Long-Term Parenteral Nutrition

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium
  • Study on the Effects of Rivaroxaban in Patients with Short Bowel Syndrome on Long-Term Parenteral Nutrition

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands
  • Study of HM15912 for Adults with Short Bowel Syndrome-associated Intestinal Failure

    Recruiting

    2 1
    Investigated Diseases:
    Belgium Denmark France Germany Poland
  • Study on Crofelemer for Adults with Short Bowel Syndrome and Intestinal Failure Without Colon in Continuity

    Recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Germany Italy
  • A Study to Evaluate the Long-Term Safety of Glepaglutide in Adult Patients with Short Bowel Syndrome Who Participated in Previous Studies

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Germany Poland
  • Study on the Long-Term Safety of Glepaglutide for Adults with Short Bowel Syndrome

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Denmark France Germany The Netherlands Poland
  • Study on the Long-Term Safety and Effectiveness of Glepaglutide for Patients with Short Bowel Syndrome

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Germany The Netherlands Poland
  • Long-term safety study of apraglutide (weekly injections) in patients with Short Bowel Syndrome

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Czechia Denmark France Germany Hungary +5